Ask AI
ProCE Banner Series

Accelerating LDL-C Control: Overcoming Clinical Inertia in the Age of Potent PCSK9 Inhibition

Join this interactive case-based webinar to explore strategies for overcoming clinical inertia, accelerating LDL-C goal attainment, and reducing residual cardiovascular risk in patients with atherosclerotic cardiovascular disease. Expert faculty will guide learners through the latest clinical evidence supporting current and emerging PCSK9-targeted therapies, including investigational oral agents, and provide practical insights on applying guideline recommendations, individualizing treatment selection, and implementing timely therapeutic intensification to optimize cardiovascular outcomes.

Date to be announced. Please check back soon for updates: DeceraClinical.com/LDLC2026 

Who Should Attend

This educational activity is intended for internal medicine physicians, nurse practitioners, and physician associates who care for patients with ASCVD.

Topics

Dyslipidemia

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners who care for patients with ASCVD.

Target Audience
This educational activity is intended for internal medicine physicians, nurse practitioners, and physician associates who care for patients with ASCVD.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify the role of elevated LDL-C as a causal driver of ASCVD progression and residual cardiovascular risk, even in optimally treated patients

  • Evaluate the latest clinical evidence for PCSK9 inhibitor therapies for patients with ASCVD

  • Implement guideline-adherent practices for LDL-C lowering and timely therapeutic intensification with PCSK9 inhibitors to achieve target reductions and optimize cardiovascular outcomes

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by educational funding provided by Amgen and Novartis Pharmaceuticals Corporation.

Amgen

Novartis Pharmaceuticals Corporation

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191